The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index; 69 of the 151 sources its claims cite were checked for support.
Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives
Open accessAbstract
Gestational diabetes mellitus (GDM) is a complication that affects 20% of pregnancies worldwide. It is associated with adverse short- and long-term cardiometabolic outcomes for both mother and infant. Effective management of GDM involves lifestyle modifications, including medical nutrition therapy (MNT) and physical activity (PA), with the addition of insulin or metformin if glycaemic control remains inadequate. However, substantial gaps persist in the determination of optimal medical nutrition therapy (MNT) for women with GDM.
Overview
CoChat Summary
TL;DR
This review summarizes current evidence and gaps in medical nutrition therapy (MNT) for gestational diabetes mellitus (GDM), emphasizing individualized calorie and macronutrient balance, carbohydrate quality/distribution, and adequate micronutrients. It concludes MNT remains the cornerstone of GDM management but implementation is limited by cultural, socioeconomic, and psychological barriers, requiring culturally tailored, multidisciplinary research.
Key findings
- MNT is a primary intervention in 30%–90% of women with GDM; combined with physical activity it improves glycaemic control and reduces macrosomia and neonatal adiposity. GDM affects over 20% of pregnancies globally.
- Caloric guidance varies: the Endocrine Society recommends 1600–1800 kcal/day or a 33% reduction for overweight/obese women with GDM. A 1200 kcal/day diet in women with GDM and BMI ≥25 kg/m² reduced long-acting insulin need (OR 0.36, 95% CI 0.18–0.70) and postnatal HbA1c (5.5% vs. 5.8%) without increased NICU admissions or SGA; 3 kg weight loss lowered LGA rates (OR 0.52, 95% CI 0.29–0.93).
- Carbohydrate minimum is 175 g/day; <42% of energy as carbohydrates may obviate insulin therapy but raises concerns about ketones. In the ROLO trial, a low-glycaemic-index diet produced less gestational weight gain (12.2 kg vs. 13.7 kg; mean difference −1.3 kg, 95% CI −2.4 to −0.2; p = 0.01) and less glucose intolerance, but did not affect LGA incidence; a meta-analysis of 11 trials involving 1985 women found LGI diets reduced fasting and postprandial glucose and LGA.
- Protein source matters: red meat was associated with a 1.48-fold increased GDM risk; replacing 5% energy from animal with vegetable protein reduced GDM risk (RR 0.49, 95% CI 0.29–0.84); in Asian populations, animal protein had OR 2.87 (95% CI 1.58–5.20). Vitamin D <20 ng/mL was associated with 26% greater GDM risk (OR 1.26, 95% CI 1.13–1.41), and vitamin D supplementation reduced GDM relative risk by 51% (95% CI 0.27–0.97); higher red blood cell folate ≥600 ng/mL was associated with GDM (aOR 1.58, 95% CI 1.03–2.41; p = 0.033).
Methods
- Narrative review with a literature search conducted up to January 2025 in PubMed, Scopus, Ovid Medline, and Ovid Embase for English-language articles.
- Excluded animal and cell studies; included prospective and retrospective observational cohort studies, randomised controlled trials, reviews, cross-sectional studies, and best-practice guidelines.
- Main analysis was a narrative synthesis of evidence on MNT, gestational weight gain, calorie and macronutrient/micronutrient requirements, cultural beliefs, hyperemesis gravidarum, and future directions; no formal meta-analysis was reported.
Limitations
- The paper states that uncertainty remains about optimal MNT, implementation is controversial, and barriers include cultural, socioeconomic, and psychological factors. It also notes that current trials are relatively small compared with diabetes prevalence, lack representation from Africans and Afro-Caribbean populations, and that included studies are heterogeneous (e.g., vitamin A assays, timing, BMI, GDM diagnostic criteria). It further states there is a lack of established biomarkers and that dietary indices such as DASH were developed for high-income countries and may not apply to lower-income countries.
- Evident from the text: as a narrative review, it does not report a systematic quality appraisal, risk-of-bias assessment, PRISMA flow, or quantitative pooling; the search strategy is described, but no formal evidence grading is presented.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
55 Valid · 5 Not valid · 52 Not checked · 17 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Emerging evidence suggests that modest energy restriction in women with GDM does not increase adverse outcomes or SGA rates compared to the baseline population [60,61,62].”
§ Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives > 5. Caloric Recommendation in Women with GDM
What the sources say
- Not checked — no full text of the sourcecites [60] Vandraas, 2013, Hyperemesis gravidarum and birth outcomes—A population-based cohort study of 2.2 million births in the Norwegian Birth Registry, BJOG Int. J. Obstet. Gynaecol. source
- Partly supportedcites [61] Catalano, 2014, Inadequate weight gain in overweight and obese pregnant women: What is the effect on fetal growth?, Am. J. Obstet. Gynecol. sourceExperimental — accuracy not yet measured
The Results (page unavailable) report no statistically significant difference in SGA risk within the GDM subgroup between women who lost weight or gained less than 5 kg and those who gained more than 5 kg. But the Methods describe an analysis of gestational weight change, not an intervention testing modest energy restriction, and the paper does not establish that adverse outcomes were unchanged relative to a baseline population. In the overall cohort, the Results instead report a higher SGA rate with weight gain of 5 kg or less. (LLM, conf=0.88)
- Disputedcites [62] Yee, 2013, Gestational weight loss and perinatal outcomes in overweight and obese women subsequent to diagnosis of gestational diabetes mellitus, Obesity sourceExperimental — accuracy not yet measured
The Results report increased SGA status and preterm delivery before 34 weeks among women who lost weight after a GDM diagnosis, compared with women who did not lose weight. This contradicts the claim that SGA rates and adverse outcomes did not increase. The study examined observed weight loss in overweight and obese women with GDM, not an intervention imposing modest energy restriction. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The challenge of MNT lies in achieving a balance between meeting the nutritional demands of pregnancy and ensuring effective blood glucose control to reduce the risk of macrosomia while simultaneously preventing starvation ketosis [14].”
§ Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives > 1. Introduction
What the sources say
- Supportedcites [14] Hernandez, 2018, Nutrition Therapy in Gestational Diabetes Mellitus: Time to Move Forward, Diabetes Care source
The introduction says nutrition in pregnancy must support maternal, placental, and fetal metabolic needs. In the historical discussion, the paper describes providing enough calories to avoid starvation ketosis while limiting carbohydrates to control postprandial hyperglycemia and reduce macrosomia risk. Page numbers are not available in our copy. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Conversely, foetal overnutrition can drive excessive insulin secretion and fat accretion, resulting in macrosomia [32].”
§ Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives > 3. Nutritional Requirements in (Normal) Pregnancy
What the sources say
- Could not verifycites [32] Heude, 2012, Pre-Pregnancy Body Mass Index and Weight Gain During Pregnancy: Relations with Gestational Diabetes and Hypertension, and Birth Outcomes, Matern. Child Health J. sourceExperimental — accuracy not yet measured
Our copy of the EDEN cohort paper is entirely epidemiological: it reports associations between pre-pregnancy BMI / net gestational weight gain and gestational diabetes, hypertension, preterm birth, SGA and LGA (Abstract p. 2; Results pp. 8-9; Discussion pp. 12-14), and contains no passage on the mechanistic pathway the claim attributes to it (foetal overnutrition -> excessive insulin secretion -> fat accretion -> macrosomia). Searches for fetal hyperinsulinaemia/Pedersen-type mechanism, maternal glucose crossing the placenta, and fat accretion returned only the Discussion (p. 14) remark that 'mechanisms other than maternal glucose concentration may be involved in the risk of macrosomia' and a p. 12 mention of maternal 'weak insulin resistance' — neither states the claimed mechanism. Absence in our copy is not contradiction, so the claim cannot be judged from this source. (LLM, conf=0.70)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Both under- and overnutrition during pregnancy can influence foetal size, body composition at birth, and long-term metabolic health [27].”
§ Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives > 3. Nutritional Requirements in (Normal) Pregnancy
What the sources say
- Partly supportedcites [27] Heidemann, 2003, Changes in maternal physiology during pregnancy, Br. J. Anaesth. CEPD Rev. sourceExperimental — accuracy not yet measured
The only passage in our copy bearing on the claim is the Endocrine section, which states that placental-hormone-driven insulin resistance makes any carbohydrate load raise maternal plasma glucose, facilitating placental glucose transfer, and that 'Poorly controlled maternal diabetes is associated with fetal macrosomia' with consequent neonatal hypoglycaemia — i.e. a maternal nutrient/glucose excess altering fetal size. Nothing in our copy addresses undernutrition, nothing addresses body composition at birth as distinct from size, and nothing addresses long-term metabolic health of the offspring (the only postnatal outcome mentioned is immediate neonatal hypoglycaemia); the paper is an obstetric-anaesthesia physiology review (Abstract, Cardiovascular/haematological, Respiratory, Renal, Hepatic, Endocrine sections) with no nutrition or developmental-programming content (searched: malnutrition/undernutrition/fetal growth restriction, nutrition/weight gain/obesity, body composition/programming/adult disease). Those unaddressed parts of the claim are not supported by this source. (LLM, conf=0.65)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maternal undernutrition may lead to foetal growth restriction (FGR), characterised by reduced pancreatic growth, impaired insulin secretion, and hepatic insulin resistance [28,29,30].”
§ Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives > 3. Nutritional Requirements in (Normal) Pregnancy
What the sources say
- Not checked — no full text of the sourcecites [28] Salam, 2013, Maternal undernutrition and intrauterine growth restriction, Expert Rev. Obstet. Gynecol. source
- Partly supportedcites [29] Thorn, 2011, The Intrauterine Growth Restriction Phenotype: Fetal Adaptations and Potential Implications for Later Life Insulin Resistance and Diabetes, Semin. Reprod. Med. sourceExperimental — accuracy not yet measured
The fetal muscle-growth section describes maternal nutrient restriction in sheep models of IUGR, and the reduced pancreatic β-cell mass and insulin production section reports smaller pancreatic islets, reduced pancreas weight, and impaired insulin secretion in growth-restricted fetuses. The increased hepatic glucose production section says the IUGR fetal liver *may be developing* insulin resistance and calls for further studies of fetal hepatic insulin sensitivity. The claim presents hepatic insulin resistance as an established characteristic rather than a possibility. (LLM, conf=0.86)
- Partly supportedcites [30] Thorn, 2013, Increased Hepatic Glucose Production in Fetal Sheep with Intrauterine Growth Restriction Is Not Suppressed by Insulin, Diabetes sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that insulin did not suppress hepatic glucose production in growth-restricted fetal sheep, and the introductory text reports decreased pancreatic insulin secretion in animal models of growth restriction. But the Methods (page unavailable) describe growth restriction induced by maternal heat exposure, not maternal undernutrition; our copy also does not establish reduced pancreatic growth. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
64 more claims · 26 with their cited sources checked
Create a free account to see all 129 claims and to verify the 14 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 48
- Borderline: one of the tests for a substantial claim is unclear. 1
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Jiang, 2022, Omega-3 fatty acids plus vitamin for women with gestational diabetes or prediabetes: A meta-analysis of randomized controlled studies, J. Matern. Fetal Neonatal Med., 35, 3135, 10.1080/14767058.2020.1814239”
Cited work 10.1080/14767058.2020.1814239 · retracted 2025-05-08 · notice 10.1080/14767058.2025.2501451 · this paper published 2025-03-30
Citations
Cites
1 retracted
Jiang, L., Gao, C., Yan, P., Chen, P., Jiang, C., Xu, Y., & Chen, M. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1814239 · Cited by 16
RetractedMaternal and child undernutrition and overweight in low-income and middle-income countries
Black, R. E., Victora, C. G., Walker, S. P., Bhutta, Z. A., Christian, P., de Onis, M., Ezzati, M., Grantham-McGregor, S., Katz, J., Martorell, R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60937-x · Cited by 8,475 · cited 1×
“Low vitamin A levels can contribute to night blindness (which affects up to 7.8% of pregnant women globally) [121].”
InfluentialGlycemic index of foods: a physiological basis for carbohydrate exchange
Jenkins, D. J., Wolever, T. M., Taylor, R. H., Barker, H., Fielden, H., Baldwin, J. M., Bowling, A. C., Newman, H. C., Jenkins, A. L., & Goff, D. V. (1981) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.3.362 · Cited by 3,857 · cited 1×
“The glycaemic index (GI), proposed by Jenkins et al. in 1981 [81], measures the rate and ability of certain foods to elevate blood glucose levels after meals compared to a standard quantity of carbohydrates.”
(2001) · National Academies Press eBooks · doi:10.17226/10026 · Cited by 3,023
Designing and developing a literature-derived, population-based dietary inflammatory index
Shivappa, N., Steck, S. E., Hurley, T. G., Hussey, J. R., & Hébert, J. R. (2014) · Public Health Nutrition · doi:10.1017/s1368980013002115 · Cited by 2,731
Dynamics of fat cell turnover in humans
Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T., et al. (2008) · Nature · doi:10.1038/nature06902 · Cited by 2,357
Does social class predict diet quality?
Darmon, N., & Drewnowski, A. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1107 · Cited by 2,250
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 1×
“Higher fasting glucose with low carbohydrate intake could be attributed to the increased release of free fatty acids in response to a lower-carbohydrate diet, leading to worsening insulin resistance [78].”
Macronutrients, P. O., Fiber, P. O. T. D. O. D., Nutrients, S. O. U. R. L. O., Intakes, S. O. I. A. U. O. D. R., Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, & Institute of Medicine (2005) · doi:10.17226/10490 · Cited by 1,482
Research works printed but not linked: 1
- Stipanuk, M.H., and Caudill, M.A. (2013). Biochemical, Physiological, and Molecular Aspects of Human Nutrition, Elsevier.
Cited by
Focus on Cell Apoptosis, Pyroptosis and Ferroptosis to Explore Strategic Breakthrough for GDM
Li, J., Fan, L., Yu, N., Wang, M., & Yang, S. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s524425 · Cited by 7
El-Hamid, S. M. A., EL-Said, F., Elkest, H. R. A., Senosy, A. M. K., Aldeeb, A. A. A., & Mohamed, M. G. (2026) · BMC Nursing · doi:10.1186/s12912-026-04290-y · Cited by 4
Beyond Glucose: The Overlooked Role of Lipids in Gestational Diabetes
Scairati, R., Laudisio, D., Imperatore, O., Masulli, M., & Colao, A. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104758 · Cited by 2
Tomczewska, K., Tomczyk, K., Kampioni, M., Kędzia, W., Rzymski, P., & Kędzia, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15010340 · Cited by 1
Altahan, L., Twynstra, J., Seabrook, J. A., & Mottola, M. F. (2026) · Healthcare · doi:10.3390/healthcare14091149 · Cited by 2
Metadata
- Authors
- Cheong, L., Law, L. S.-C., Tan, L. Y. L., Amal, A. A.-A., Khoo, C. M., & Eng, P. C.
- Affiliations
- National University Hospital (SG)
- Department of Internal Medicine, Nizwa Hospital, Nizwa P.O. Box 1222, Oman
- Corresponding author
- Eng, Pei Chia
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2025-03-30
- Volume
- 17
- Issue
- 7
- Pages
- 1210
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC11990351
- OpenAlex
- W4408991556
- Cited by
- 14
- References
- 179
- Citations by year
- 2026: 11 · 2025: 3
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Exxon Mobil-NUS Research Fellowship grant (exxonmobil2023, CNIG23jul-0001)
- National Medical Research Council New Investigator grant (exxonmobil2023, CNIG23jul-0001)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- gestational diabetes mellitus, medical nutrition therapy, glycemic control, macronutrient distribution, carbohydrate intake, micronutrient deficiency, hyperemesis gravidarum, dietary adherence, maternal and fetal outcomes, personalized nutrition
- MeSH terms
- Female, Humans, Pregnancy, Exercise, Diabetes, Gestational, Maternal Nutritional Physiological Phenomena, Nutrition Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives. https://app.cochat.ai/papers/10.3390/nu17071210
- The paper
- Cheong, L., Law, L. S.-C., Tan, L. Y. L., Amal, A. A.-A., Khoo, C. M., & Eng, P. C. (2025). Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives. Nutrients. https://doi.org/10.3390/nu17071210
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
